[Skip to Content]
[Skip to Content Landing]
Views 659
Citations 0
Invited Commentary
June 2015

Screening Strategies for Pancreatic Cancer in High-Risk Patients: Opportunities to Make a Real Impact But Many Questions and Challenges Still Ahead

Author Affiliations
  • 1Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois
 

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Surg. 2015;150(6):518-519. doi:10.1001/jamasurg.2015.0391

In this issue of JAMA Surgery, Del Chiaro and colleagues1 report the early results of a magnetic resonance imaging (MRI)–based Swedish screening program for asymptomatic patients with an increased risk for familial pancreatic cancer. The goals of this study were to determine whether a high-risk population of patients could be screened in a cost-efficient fashion with a noninvasive screening test and whether this strategy yielded enough premalignant lesions and early cancers to justify the strategy.

×